Description
"Cardiovascular Disease, the Number One Killer" brings Peter Attia (MD) and Tom Dayspring (MD) together to explore what drives heart disease from its earliest stages. They explain why apoB is a more predictive marker than LDL, how cholesterol interacts with other risk factors, and what role insulin resistance and kidney health may play. The episode also looks at links between lipids and brain function, offering practical insight on lifestyle and medication strategies that can shift cardiovascular risk long term.
Cardiovascular Disease: The Number One Killer
Guest
Tom Dayspring
Category
Cardiovascular Health, Metabolic Health
Tags
About The Host
Peter Attia (MD) is a physician specializing in longevity, metabolic health, and peak performance. He hosts The Peter Attia Drive, where he interviews experts on aging, chronic disease, and the science of extending healthspan. His bestselling book "Outlive: The Science and Art of Longevity" provides a roadmap for living longer and better through early prevention, strategic exercise, nutrition, and personalized medical insight.
Peter Attia (MD) is a physician specializing in longevity, metabolic health, and peak performance. He hosts The Peter Attia Drive, where he interviews experts on aging, chronic disease, and the science of extending healthspan. His bestselling book "Outlive: The Science and Art of Longevity" provides a roadmap for living longer and better through early prevention, strategic exercise, nutrition, and personalized medical insight.
About The Guest
Tom Dayspring (MD, FACP, FNLA) is a lipidologist and internal medicine specialist with a focus on cardiovascular prevention and advanced lipid testing. He has taught thousands of clinicians about biomarkers like apoB and Lp(a), reshaping how heart disease risk is assessed. A fellow of both the American College of Physicians and the National Lipid Association, Dr. Dayspring is known for making complex lipoprotein science clinically relevant and actionable.
Tom Dayspring (MD, FACP, FNLA) is a lipidologist and internal medicine specialist with a focus on cardiovascular prevention and advanced lipid testing. He has taught thousands of clinicians about biomarkers like apoB and Lp(a), reshaping how heart disease risk is assessed. A fellow of both the American College of Physicians and the National Lipid Association, Dr. Dayspring is known for making complex lipoprotein science clinically relevant and actionable.
Support the Guest
This episode does not include any guest appearances, or information about the guests' website, Instagram, Facebook, or Twitter profiles is currently unknown to us. We’ll update this page as soon as more details become available.